Matt Kaeberlein discusses the complex effects of rapamycin on mTOR complex one and two, and how chronic inhibition of mTOR complex one can potentially lead to activation or inhibition of mTOR complex two. He also explores the link between rapamycin and glucose intolerance, highlighting the need for further research to fully understand the mechanisms at play.
